CTRI/2020/07/026362
Not Yet Recruiting
N/A
CLINICAL EVALUATION OF THE THERAPEUTIC EFFICACY OF SARVAKALPA-GHAN-VATI IN NON-ALCOHOLIC LIVER DISORDER.
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Health Condition 1: K77- Liver disorders in diseases classified elsewhere
- Sponsor
- Patanjali Research Institute
- Status
- Not Yet Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\)Patients between the age group of 18\-65 years will be selected.
- •2\)Patients irrespective of sex, religion, occupation and chronicity will be selected for the study.
- •3\)Both fresh and treated cases would be taken for the study.
- •4\)Patients with higher LFT levels than the upper limit of normal value will be selected.
- •5\)Patients with GRADE 1 and GRADE 2 fatty liver will be selected for the study.
- •6\)Patient with controlled Diabetes mellitus having GRADE 1 and GRADE 2 fatty liver will be selected for the study.
Exclusion Criteria
- •1\)Patients aged \<18 years or \>65 years will be excluded.
- •2\)Pregnant or lactating women will be excluded.
- •3\)Patients who had hepatitis B, C or other hepatic viral infection, autoimmune hepatitis and drug\-induced hepatitis or alcoholic hepatitis will be excluded.
- •4\)Patients with severe complications of the cardiovascular, renal or hematopoietic systems and mental diseases will be excluded.
- •5\)Patients will be excluded having decompensated liver disease.
- •6\)Patients with prolonged or a history of ascites, developed hepato\-cellular carcinoma, hepatic encephalopathy, variceal bleeding will be excluded.
- •7\)Patients with a history of using IFN or antiviral agents or corticosteroids or immunosuppressive drugs will also be excluded.
- •8\)Patients having GRADE 3 fatty liver disease will be excluded
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Ayurvedic Management Of Hepatitis BHealth Condition 1: K739- Chronic hepatitis, unspecifiedCTRI/2018/05/014023Patanjali Ayurveda College50
Not Yet Recruiting
Phase 1
Role of sarvakalpa ghan vati in liver disease.Health Condition 1: K768- Other specified diseases of liverCTRI/2020/06/025733Dr Zeba Malik
Completed
Phase 2
Treatment of schizophrenia with antipsychotic drugsSchizopherenia.SchizophreniaIRCT138706051100N1Deputy of Research, Tehran University of Medical Sciences28
Completed
N/A
An investigation of the clinical effectiveness of fixing the probe to the skin during ultrasound-guided central venous cannulation.Patients undergoing central venous cannulationJPRN-UMIN000009237Hirosaki University Graduate School of Medicine280
Completed
Phase 2
Evaluation of the therapeutic effects of Iranian Traditional Medicine (Hab Shabyar) in patients with open-angle glaucoma: A double-blind clinical trialopen-angle glaucoma.Primary open-angle glaucomaIRCT2016052828127N1Vice Chancellor for Research (VCR) of Tabriz University of Medical Sciences50